(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TSB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TSB

ST13

US500000085022695

Class

5

Filing

85022695

Registration

4068077

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

12/23/2022

Trademark type

Combined

Nice classes

5

Filing date

04/26/2010

Registration date

12/06/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/08/2021

Last transaction

11/08/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/01/2011

First use in commerce

10/01/2011

Drawing code

3

Owner type

03

Owner location

TAUYUAN, TW

Examiner

BEN, LINDSEY

Law office

L80

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the letters "TSB" having a broken line going through the bottom of the letters and five circles with light spots in the upper left hand corner starting next to the letter "T" and continuing above the letters "TSB" and getting smaller in size and ending to the right of the letter "B".

Holders and representatives

Holders

Taiwan Sunpan Biotechnology DevelopmentCo., Ltd.
Taiwan Sunpan Biotechnology Development Co., Ltd.

Representatives

Joe McKinney Muncy Muncy, Geissler, Olds & Lowe, P.C

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicinal herbal preparationsgalenicals; oral analgesics; anti-inflammatory drugs; prescription synthetic and extracted narcotics; anti-carcinogen preparation; anti-diabetes preparationpharmaceutical preparations for treating diabetes; cholesterol lowering drugs; antidiarrheal preparationsdiarrhea medication; antineoplastic agentspharmaceutical preparations for use in chemotherapy and in curing tumors and cancer; anti-hypertension drugs; western pharmaceutical preparations for use in or as antidepressantsanticoagulantsanti-cancer drugs; Chinese herbal pharmaceutical preparationsmedicinal herbal preparations; medicine and pharmaceutical preparations for central nervous system; cardiovascular agentscardiovascular treatment preparations and cardiovascular pharmaceuticals; pharmaceutical preparations for preventing and curing hypertension and circulatory system diseases; medicine and pharmaceutical preparations for human usesedativesantiallergic medicinespharmaceutical preparationssynthetic or extracted pharmaceutical preparations for oral or injection administration to cure cancertumorsdiseasesanti-convulsion preparationsmedicines for the human brain; antiviral agents; antispasmodicspharmaceutical preparations to relieve cramps or spasms of the stomachintestinesbladder

Publications

History of USPTO decisions and trademark events.

46 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/23/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/23/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/23/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/23/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/08/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/08/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/08/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/08/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

06/24/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/06/2020

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/23/2017

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/23/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/22/2017

ES8R

TEAS SECTION 8 RECEIVED

02/07/2017

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/06/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

12/06/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/04/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

11/03/2011

ALIE

ASSIGNED TO LIE

11/01/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/31/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/20/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/20/2011

IUAF

USE AMENDMENT FILED

10/19/2011

EISU

TEAS STATEMENT OF USE RECEIVED

10/19/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/12/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/17/2011

PUBO

PUBLISHED FOR OPPOSITION

05/17/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/13/2011

ALIE

ASSIGNED TO LIE

04/10/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/04/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/04/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/04/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/04/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/08/2011

GNRT

NON-FINAL ACTION E-MAILED

02/08/2011

CNRT

NON-FINAL ACTION WRITTEN

02/08/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/19/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/19/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/19/2011

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/05/2010

GNRT

NON-FINAL ACTION E-MAILED

08/05/2010

CNRT

NON-FINAL ACTION WRITTEN

08/05/2010

DOCK

ASSIGNED TO EXAMINER

08/05/2010

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

04/30/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/29/2010

NWAP

NEW APPLICATION ENTERED

04/29/2010

Continuous trademark protection

Get notified about every new filing that threatens TSB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.